adaptor-related protein complex 2, alpha 2 subunit

http://metadb.riken.jp/db/mgi_rdf/MGI:101920

adaptor-related protein complex 2, alpha 2 subunit

marker

発現マップ

http://vibrism.neuroinf.jp/dev/201509/rdf/mgiGene

• ExpressionMap(C57BL/6J,7day,male):Cf022498
  http://vibrism.neuroinf.jp/dev/201509/rdf/ExpressionMap/C57BL_6J_7day_male/Cf022498
• ExpressionMap(C57BL/6J,8week,male):Cx106890
  http://vibrism.neuroinf.jp/dev/201509/rdf/ExpressionMap/C57BL_6J_8week_male/Cx106890
• ExpressionMap(C57BL/6J,8week,male):Cx121044
  http://vibrism.neuroinf.jp/dev/201509/rdf/ExpressionMap/C57BL_6J_8week_male/Cx121044
• ExpressionMap(C57BL/6J,3week,male):Cg000260
  http://vibrism.neuroinf.jp/dev/201509/rdf/ExpressionMap/C57BL_6J_3week_male/Cg000260
• ExpressionMap(C57BL/6J,3day,male):Ce020898
  http://vibrism.neuroinf.jp/dev/201509/rdf/ExpressionMap/C57BL_6J_3day_male/Ce020898
• ExpressionMap(C57BL/6J,8week,male):Cx118848
  http://vibrism.neuroinf.jp/dev/201509/rdf/ExpressionMap/C57BL_6J_8week_male/Cx118848

シノニム

http://metadb.riken.jp/db/mgi_rdf/Marker_Synonyms

genome coordinate end

http://metadb.riken.jp/db/mgi_rdf/genome_coordinate_end

シンボル

http://metadb.riken.jp/db/mgi_rdf/Marker_Symbol

染色体

http://metadb.riken.jp/db/mgi_rdf/MouseChromosome

Feature Type

http://metadb.riken.jp/db/mgi_rdf/Feature_Type

位置（遺伝的距離）

http://metadb.riken.jp/db/mgi_rdf/cM_Position

strand

http://metadb.riken.jp/db/mgi_rdf/strand

See also (jump to original page)

http://www.w3.org/2000/01/rdf-schema#seeAlso

Marker Type

http://metadb.riken.jp/db/mgi_rdf/Marker_Type

MGI Accession ID

http://metadb.riken.jp/db/mgi_rdf/MGI_ID

genetic mapping procedure

http://metadb.riken.jp/db/mgi_rdf/genetic_mapping_procedure

genome coordinate start

http://metadb.riken.jp/db/mgi_rdf/genome_coordinate_start

Status

http://metadb.riken.jp/db/mgi_rdf/Status

トランスクリプトームデータ

http://metadb.riken.jp/db/BrainTx/mgiGene

• CD08629
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD08629

解析対象遺伝子型

http://metadb.riken.jp/db/bioresource_schema/brs_ofGene

• Ap2a2<em1(IMPC)Wtsi>/Ap2a2<+>
  http://metadb.riken.jp/db/IMPC_RDF/Genotype/Ap2a2_em1(IMPC)Wtsi-Ap2a2_+
• Ap2a2<tm1b(EUCOMM)Wtsi>/Ap2a2<tm1b(EUCOMM)Wtsi>
  http://metadb.riken.jp/db/IMPC_RDF/Genotype/Ap2a2_tm1b(EUCOMM)Wtsi-Ap2a2_tm1b(EUCOMM)Wtsi
• Ap2a2<tm1b(EUCOMM)Wtsi>/Ap2a2<+>
  http://metadb.riken.jp/db/IMPC_RDF/Genotype/Ap2a2_tm1b(EUCOMM)Wtsi-Ap2a2_+

allele

http://metadb.riken.jp/db/mgi_rdf/variant_of

• Ap2a2<tm1b(EUCOMM)Wtsi>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5548327
• Ap2a2<tm1(KOMP)Vlcg>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4951299
• Ap2a2<tm1a(EUCOMM)Wtsi>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4888954

表現型アノテーション

http://metadb.riken.jp/db/mgi_rdf/variant_of

• absent pinna reflex_Ap2a2<tm1b(EUCOMM)Wtsi>/Ap2a2<tm1b(EUCOMM)Wtsi>
  http://metadb.riken.jp/0006358C57BL6NAp2a2tm1bEUCOMMWtsiWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsi
• decreased lumbar vertebrae number_Ap2a2<tm1b(EUCOMM)Wtsi>/Ap2a2<tm1b(EUCOMM)Wtsi>
  http://metadb.riken.jp/0004647C57BL6NAp2a2tm1bEUCOMMWtsiWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsi
• increased sacral vertebrae number_Ap2a2<tm1b(EUCOMM)Wtsi>/Ap2a2<tm1b(EUCOMM)Wtsi>
  http://metadb.riken.jp/0010101C57BL6NAp2a2tm1bEUCOMMWtsiWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsi
• decreased circulating serum albumin level_Ap2a2<tm1b(EUCOMM)Wtsi>/Ap2a2<tm1b(EUCOMM)Wtsi>
  http://metadb.riken.jp/0005419C57BL6NAp2a2tm1bEUCOMMWtsiWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsi
• increased circulating LDL cholesterol level_Ap2a2<tm1b(EUCOMM)Wtsi>/Ap2a2<tm1b(EUCOMM)Wtsi>
  http://metadb.riken.jp/0000182C57BL6NAp2a2tm1bEUCOMMWtsiWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsi
• increased circulating free fatty acid level_Ap2a2<tm1b(EUCOMM)Wtsi>/Ap2a2<+>
  http://metadb.riken.jp/0001554C57BL6NAp2a2tm1bEUCOMMWtsiWtsiAp2a2tm1bEUCOMMWtsiAp2a2Ap2a2Ap2a2tm1bEUCOMMWtsi
• increased circulating HDL cholesterol level_Ap2a2<tm1b(EUCOMM)Wtsi>/Ap2a2<tm1b(EUCOMM)Wtsi>
  http://metadb.riken.jp/0001556C57BL6NAp2a2tm1bEUCOMMWtsiWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsi
• decreased circulating fructosamine level_Ap2a2<tm1b(EUCOMM)Wtsi>/Ap2a2<tm1b(EUCOMM)Wtsi>
  http://metadb.riken.jp/0010088C57BL6NAp2a2tm1bEUCOMMWtsiWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsi
• decreased mean corpuscular volume_Ap2a2<tm1b(EUCOMM)Wtsi>/Ap2a2<tm1b(EUCOMM)Wtsi>
  http://metadb.riken.jp/0002591C57BL6NAp2a2tm1bEUCOMMWtsiWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsi
• increased circulating alkaline phosphatase level_Ap2a2<tm1b(EUCOMM)Wtsi>/Ap2a2<tm1b(EUCOMM)Wtsi>
  http://metadb.riken.jp/0002968C57BL6NAp2a2tm1bEUCOMMWtsiWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsi
• increased circulating cholesterol level_Ap2a2<tm1b(EUCOMM)Wtsi>/Ap2a2<tm1b(EUCOMM)Wtsi>
  http://metadb.riken.jp/0005178C57BL6NAp2a2tm1bEUCOMMWtsiWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsiAp2a2tm1bEUCOMMWtsi